New Zealand Health Terminology Service (NZHTS) Implementation Guide
0.1.0 - ci-build
New Zealand Health Terminology Service (NZHTS) Implementation Guide, published by Health New Zealand | Te Whatu Ora. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/daniel-thomson/nzhts/ and changes regularly. See the Directory of published versions
Official URL: https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-testicular-adnexa-site-histology | Version: 0.1.0 | |||
Active as of 2024-11-11 | Computable Name: canshare-who-testicular-adnexa-site-histology | |||
Other Identifiers: http://canshare.co.nz/fhir/NamingSystem/valuesets#canshare-who-testicular-adnexa-site-histology |
Histologies used for testicular adnexa sites, from WHO Classification of Tumours, Urinary & Male Genital Tumours (latest edition) - Sections 7. Tumours of the testicular adnexa, 9. Neuroendocrine neoplasms, 11. Haematolymphoid tumours, 12. Melanocytic lesions or an 'Other' value.
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
Generated Narrative: ValueSet canshare-who-testicular-adnexa-site-histology
version: 1; Last updated: 2024-11-05 17:14:30+1300; Language: en-x-sctlang-23162100-0210105
http://snomed.info/sct
where constraint = ^300391000210108 |New Zealand World Health Organization classification of tumors 5th edition urinary and male genital testicular adnexa histology reference set| OR ^300411000210108 |New Zealand World Health Organization classification of tumors 5th edition urinary and male genital neuroendocrine histology reference set| OR ^300431000210101 |New Zealand World Health Organization classification of tumors 5th edition urinary and male genital hematolymphoid histology reference set| OR ^300441000210109 |New Zealand World Health Organization classification of tumors 5th edition urinary and male genital melanocytic lesion histology reference set| OR 74964007 |Other|
Generated Narrative: ValueSet canshare-who-testicular-adnexa-site-histology
version: 1; Last updated: 2024-11-05 17:14:30+1300; Language: en-x-sctlang-23162100-0210105
Expansion based on SNOMED CT 21000210109 edition 01-Oct 2024
This value set contains 38 concepts
Code | System | Display - English (English, en) |
2348006 | http://snomed.info/sct | Adenomatoid tumour |
1187227004 | http://snomed.info/sct | Benign adenomatous neoplasm |
253051001 | http://snomed.info/sct | Benign Brenner tumour |
299651000210108 | http://snomed.info/sct | Benign well-differentiated papillary mesothelioma |
30546008 | http://snomed.info/sct | Clear cell adenocarcinoma |
448546006 | http://snomed.info/sct | Combined large cell neuroendocrine carcinoma |
47620003 | http://snomed.info/sct | Cystadenoma |
1172695008 | http://snomed.info/sct | Diffuse large B cell lymphoma |
75987005 | http://snomed.info/sct | Endometrioid adenoma, borderline malignancy |
30289006 | http://snomed.info/sct | Endometrioid carcinoma |
65278006 | http://snomed.info/sct | Epithelioid mesothelioma, malignant |
51747000 | http://snomed.info/sct | Extra-adrenal paraganglioma |
397350003 | http://snomed.info/sct | Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue |
262481000210107 | http://snomed.info/sct | Juvenile xanthogranuloma |
128628002 | http://snomed.info/sct | Large cell neuroendocrine carcinoma |
1186968006 | http://snomed.info/sct | Malignant adenomatous neoplasm |
1513001 | http://snomed.info/sct | Melanotic neuroectodermal tumour |
30383009 | http://snomed.info/sct | Mesothelioma, biphasic, malignant |
62064005 | http://snomed.info/sct | Mesothelioma, malignant |
785766008 | http://snomed.info/sct | Mixed neuroendocrine-non neuroendocrine neoplasm |
79143006 | http://snomed.info/sct | Mucinous cystadenocarcinoma |
67182003 | http://snomed.info/sct | Mucinous cystadenoma |
128852007 | http://snomed.info/sct | Mucinous cystic tumour of borderline malignancy |
301341000210107 | http://snomed.info/sct | Mucosal melanoma |
733844008 | http://snomed.info/sct | Neuroendocrine type combined small cell carcinoma |
2142002 | http://snomed.info/sct | Nodular melanoma |
74964007 | http://snomed.info/sct | Other |
32140001 | http://snomed.info/sct | Papillary cystadenoma |
128921005 | http://snomed.info/sct | Plasmacytoma, extramedullary (not occurring in bone) |
399477001 | http://snomed.info/sct | Sarcomatoid mesothelioma |
301241000210101 | http://snomed.info/sct | Serous cystadenocarcinoma |
51608009 | http://snomed.info/sct | Serous cystadenoma |
128849004 | http://snomed.info/sct | Serous cystadenoma, borderline malignancy |
74364000 | http://snomed.info/sct | Small cell neuroendocrine carcinoma |
1162767002 | http://snomed.info/sct | Squamous cell carcinoma |
1286768001 | http://snomed.info/sct | Well-differentiated neuroendocrine tumour |
1286769009 | http://snomed.info/sct | Well-differentiated neuroendocrine tumour grade 1 |
1286770005 | http://snomed.info/sct | Well-differentiated neuroendocrine tumour grade 2 |
Explanation of the columns that may appear on this page:
Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
Code | The code (used as the code in the resource instance) |
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
Definition | An explanation of the meaning of the concept |
Comments | Additional notes about how to use the code |